14 - 16 June, 2010
Tel-Aviv
the ILSI Biomed 2010 Conference will focus on: - The role of innovation, its source – industry or academia? Who will pay for it? – venture capital or large medical and biopharma companies?
- Regulatory changes and their impact on innovation
- Does personalized medicine mean smaller target markets?
- Who is better suited to commercialize future “niche” products? Large players or innovative fully integrated companies. How would it impact business models?
|
|
